[Correspondence] CSF dynamics in idiopathic normal pressure hydrocephalus

Author profile image Aggregator
0 comments
Two randomised trials in idiopathic normal pressure hydrocephalus have been published in the past 12 months. In DRAIN,1 acetazolamide, which reduces CSF production, did not improve gait in patients with idiopathic normal pressure hydrocephalus when compared with placebo: the adjusted between-group difference in composite gait score was 0·09 units (95% CI −3·61 to 3·79; p=0·96). In PENS,2 by contrast, in which patients underwent shunt surgery, the open-shunt setting increased gait velocity relative to the placebo valve setting by 0·21 m/s (95% CI 0·12 to 0·31; p<0·001) at 3 months.

Source: The Lancet Neurology - Current Issue Published 30 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article